e-learning
resources
Glasgow 2004
Sunday 05.09.2004
COPD: insights from structure and function
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interaction of hemostasis (H) and immune response (IR) in COPD development
A. E. Makarevich (Minsk, Belarus)
Source:
Annual Congress 2004 - COPD: insights from structure and function
Session:
COPD: insights from structure and function
Session type:
Thematic Poster Session
Number:
832
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. E. Makarevich (Minsk, Belarus). Interaction of hemostasis (H) and immune response (IR) in COPD development. Eur Respir J 2004; 24: Suppl. 48, 832
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Viral infection (VI) and role of oxidative stress (OS) in asthma exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004
Humoral immune response to recombinant and native mycobacterial antigens in different forms of pulmonary tuberculosis (TB) in adults (A) and children (C)
Source: Eur Respir J 2004; 24: Suppl. 48, 32s
Year: 2004
Relationship between salivary markers of oxidative stress (OS) and different levels of control of bronchial asthma (BA).
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Transforming growth factor beta (TGF-β) augments rhinovirus (RV) replication in primary bronchial epithelial cells (pbecs) through modulation of the innate immune response
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
Time course relationships of Type 1 and 2 inflammatory and innate immune pathways during Human Rhinovirus (HRV) infection in subjects with asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Host response (immune response)
Source: Virtual Congress 2020 – Basic science
Year: 2020
COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012
Reproducibility of resistance (R) and reactance (X) responses to bronchodilator (BD) measured by the impulse oscillation system (IOS) in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Pulmonary function test (PT) and physical fitness (F) in asthmatic children
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005
Is the strength of the type-2 (T2) inflammatory biomarker signal important in determining the burden of disease in severe asthma (SA)?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Increased METEORIN-LIKE (ML) expression promotes lung inflammation in asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Frequency of autoantibodies (autoAb) and circulating immune complexes (CI) occurrences in pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 313s
Year: 2002
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Host response (airway/lung effects)
Source: Virtual Congress 2020 – Basic science
Year: 2020
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Source: Eur Respir J 2009; 34: 219-230
Year: 2009
Dose-dependent effects of salbutamol (S) and fenoterol (F) in patients with bronchial asthma (BA) and ischaemic heart disease (IHD)
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept